Lung Cancer Clinical Trial

ENDO GIAâ„¢ Stapler With ENDO GIAâ„¢ Reload With Tri-Stapleâ„¢ Technology in a Pulmonary Resection

Summary

The objectives of this clinical trial are to compare the incidence and duration of air leaks and the incidence of prolonged air leaks (defined as > 5 days by the Society for Thoracic Surgery) when using the ENDO GIAâ„¢ Stapler with ENDO GIAâ„¢ SULU with TRI-STAPLEâ„¢ Technology in a pulmonary resection via Video Assisted Thoracoscopic Surgery (VATS).

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

The subject must be 18 years of age or older.
The subject must be scheduled to undergo wedge resection or lobectomy via Video Assisted Thoracoscopic Surgery (VATS) for a lung nodule suspicious for or clinically proven to be primary lung cancer.
The subject must be able to tolerate general anesthesia and have cardiopulmonary reserve to tolerate the procedure.
The subject must be willing and able to comply with all study requirements and have understood and signed the informed consent.

Exclusion Criteria:

The subject is pregnant or breastfeeding.
The subject is scheduled to undergo sleeve lobectomy, segmentectomy, bi-lobectomy, pneumonectomy or Lung Volume Reduction Surgery (LVRS), or lung biopsy for suspected interstitial lung disease.
A rib-spreading thoracotomy incision is scheduled to be performed, however the use of an access incision without rib-spreading for specimen removal or to facilitate hilar dissection is allowed. VATS procedures that are converted in the operating room to open procedures are not exclusionary.
The subject has received pre-operative chemotherapy or radiation therapy for the lung cancer that will be resected.
The subject is scheduled to receive intra-operative brachytherapy.
The subject has other severe illnesses that would preclude surgery such as unstable angina or myocardial infarction within 3 months.
Re-operative surgery is excluded if it is on the same side as the previous surgery.
Investigator determines that participation in the study may jeopardize the safety or welfare of the subject.
The subject is unable to comply with the follow-up visit schedule

Study is for people with:

Lung Cancer

Estimated Enrollment:

50

Study ID:

NCT01241565

Recruitment Status:

Completed

Sponsor:

Medtronic - MITG

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 3 Locations for this study

See Locations Near You

Cedar Sinai Medical Center
Los Angeles California, 90048, United States
Advocate Christ Medical Center
Oak Lawn Illinois, 60453, United States
Mayo Clinic
Rochester Minnesota, 55905, United States

How clear is this clinincal trial information?

Study is for people with:

Lung Cancer

Estimated Enrollment:

50

Study ID:

NCT01241565

Recruitment Status:

Completed

Sponsor:


Medtronic - MITG

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider